Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease

Liver Transplantation

Volumn 7, Issue 2, 2001, Pages 154-157

  Rajvanshi, Pankaj ^a   McDonald, George B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; HUMAN; LIVER DYSFUNCTION; LIVER NECROSIS; LIVER TRANSPLANTATION; LIVER VEIN; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; PARAMETER; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; TREATMENT FAILURE; VEIN OCCLUSION; VENOUS PRESSURE;

EID: 0035109211     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.0070154     Document Type: Article

References (25)

1. Current management of the Budd-Chiari syndrome
2. Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome
3. Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome
4. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation
5. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation
6. Successful treatment of hepatic veno-occlusive disease in a peripheral blood progenitor cell transplant patient with a transjugular intrahepatic portosystemic stent-shunt (TIPS)
7. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease
8. Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms
9. Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation
10. Decrease in hepatic nitric oxide production contributes to hepatic veno-occlusive disease (HVOD)
11. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients
12. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: A case for evidence-based guidelines
13. Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients
14. Hepatobiliary complications of the hematopoietic cell transplantation
15. Transjugular liver biopsy in bone marrow transplantation
16. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients
17. Venocclusive disease of the liver: Development of a model for predicting fatal outcome after marrow transplantation
18. Successful treatment of hepatic venoocclusive liver disease in a bone marrow transplant patient with orthotopic liver transplantation
19. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant
20. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation-Clinical and immunological considerations
21. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver
22. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Chronic Leukemia Working Party
23. Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: Incidence, risk factors, and outcome
24. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
25. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts